OMV OE TL 16.5166 / 17.7561/ AT0000A2MAS3 /
2024-08-02 5:27:42 PM | Chg.-0.06 | Bid5:27:42 PM | Ask2024-08-02 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.27EUR | -2.58% | 2.27 Bid Size: - |
2.06 Ask Size: - |
OMV AG | 16.5166 EUR | 2078-12-31 | Call |
GlobeNewswire
03-26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
01-16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
2023-09-14
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
2021-10-13
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center